Target intelligence / Profile preview

Zinc-activated ligand-gated ion channel (ZACN)

Target
ZACN
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor
01

Overview

The **zinc-activated ligand-gated ion channel (ZACN)** is a member of the Cys-loop receptor superfamily, which encompasses pentameric ligand-gated ion channels such as nicotinic acetylcholine, 5-HT3, GABA_A, and glycine receptors[1][4]. ZACN forms a cation-selective ion channel that is gated primarily by Zn^2+, but also by Cu^2+ and H^+, and is non-selectively permeable to monovalent cations such as Na^+, K^+, and Cs^+[1][4]. In contrast to other Cys-loop receptors, ZACN is *not* permeable to divalent cations like Ca^2+ and Mg^2+; these ions instead inhibit the channel[1]. ZACN is broadly expressed in human tissues, including the brain, spinal cord, and various peripheral organs, but is absent from rodent genomes[4]. Because its agonist, Zn^2+, is a key modulator in the nervous system, ZACN has been proposed to serve as a Zn^2+ sensor and may play a role in metal ion homeostasis and signal transduction[2][3]. Structural and functional data suggest ZACN's unique properties distinguish it from better-known Cys-loop receptors, though its precise physiological and pathological significance remains under study[2][3][1]. There are currently no approved drugs targeting ZACN, and its full disease association and biomarker relevance have not been established.

Other names
Ligand-gated cation channel ZACNZACNL2LGICZZACLGICZ1ZAC1Ligand-gated ion channel zinc-activated 1Ligand-gated ion-channel receptor L2Zinc-activated channelligand-gated ion channel subunitzinc-activated ligand-gated ion channel
02

Mechanism of action

Channel agonism (by Zn^2+, Cu^2+, H^+), channel inhibition (by Ca^2+, Mg^2+)

03

Biological functions

Signal transductionNeurotransmissionPossible Zn^2+ sensing
04

Disease associations

Neurodegenerative diseaseOther (potential roles in disorders regulated by or involving Zn^2+, Cu^2+, or H+ signaling)
05

Safety considerations

Limited characterizationpotential off-target effects unknownrelevance to human disease remains underexplored

Beyond the preview

Go deeper on Zinc-activated ligand-gated ion channel (ZACN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-activated ligand-gated ion channel (ZACN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call